Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

Clinical trial NCT05406206 · UNKNOWN

Trial details

NCT number: NCT05406206
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Colorectal Carcinoma Liver Metastasis Colon Cancer

Start date: 2022-02-25
Primary completion: 2023-07-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.